Related Experiment Videos
Central action of ergometrine.
Polish Journal of Pharmacology and Pharmacy
|November 1, 1976
Summary
Ergometrine, a dopamine receptor stimulant, did not enhance normal locomotor activity but counteracted drug-induced depression. Its central effects, including hypothermia and catalepsy antagonism, resemble apomorphine, suggesting complex neurological interactions.
Area of Science:
- Neuropharmacology
- Central Nervous System (CNS) Research
Background:
- Ergometrine is known as a spasmolytic agent with dopamine receptor stimulating properties.
- Its potential as a central nervous system stimulant has not been fully explored.
Purpose of the Study:
- To investigate the central stimulant potential of ergometrine.
- To characterize ergometrine's effects on locomotor activity, catalepsy, ptosis, and body temperature in animal models.
Main Methods:
- Assessment of locomotor activity in normal rats and mice.
- Evaluation of ergometrine's effects on reserpine-, spiroperidol-, and pimozide-induced locomotor depression.
- Analysis of ergometrine's ability to antagonize neuroleptic-induced catalepsy, reserpine-induced ptosis, and hypothermia.
- Investigation of ergometrine-induced hypothermia and its antagonism by other drugs.
Main Results:
- Ergometrine did not affect normal locomotor activity but elevated activity depressed by reserpine, spiroperidol, and pimozide.
- Ergometrine antagonized neuroleptic-induced catalepsy and reversed reserpine-induced ptosis and hypothermia.
- Ergometrine induced hypothermia, which was antagonized by pimozide, spiroperidol, and haloperidol, but not atropine.
Conclusions:
- Ergometrine exhibits complex central nervous system effects, acting as an antagonist to certain neuroleptic-induced behaviors.
- The hypothermic effect of ergometrine is dopamine-mediated.
- Ergometrine's central actions share similarities with apomorphine, indicating a potential role in dopaminergic pathways.